Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The study is designed to compare the pharmacokinetics of generic tacrolimus (Sandoz) to
branded tacrolimus (Prograf) in stable renal transplant patients.